NDAINTRAVENOUSINJECTABLE
Approved
Sep 1999
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Drug data last refreshed 3d ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SYNERCID is an intravenous streptogramin antibiotic combining dalfopristin and quinupristin, used to treat serious infections caused by gram-positive bacteria. It is indicated for skin and soft tissue infections and hospital-acquired pneumonia caused by resistant pathogens. The drug works by inhibiting bacterial protein synthesis through a dual mechanism of action.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure; expect downsizing of brand team and transition toward generic transition planning.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients
Started Jun 2000
Gram-Positive Bacterial Infections
Career Relevance
SYNERCID offers limited career growth opportunities given its approaching LOE status and minimal linked job openings. Roles available are primarily focused on defending market share against generics and managing the decline phase of the product lifecycle.
Brand Manager
Worked on SYNERCID at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.